Table III.
Platelet-rich plasma quality, cellular and growth factor correlations with Achilles Tendon Rupture Score at two years.
| Parameter | n | r | % variance* | p-value† | 
|---|---|---|---|---|
| Cell count | ||||
| Red blood cell count | 77 | 0.011 | 0.011 | 0.927 | 
| White blood cell count | 77 | < 0.001 | < 0.001 | 0.996 | 
| Platelet count‡ | 74 | 0.065 | 0.419 | 0.584 | 
| Platelet quality | ||||
| Activated CD62p expression (%) | 77 | -0.119 | 1.411 | 0.303 | 
| Mean fluorescence intensity | 77 | 0.025 | 0.065 | 0.826 | 
| Growth factor | ||||
| IGF-1 | 78 | 0.059 | 0.347 | 0.608 | 
| TGF-β1 | 75 | 0.0672 | 0.452 | 0.567 | 
| PDGF-AB | 76 | -0.076 | 0.580 | 0.513 | 
| VEGF | 78 | -0.165 | 2.706 | 0.150 | 
| FGFb | 78 | 0.041 | 1.168 | 0.722 | 
Proportion of variance in Achilles Tendon Rupture Score at two years explained by key blood parameter, calculated as: ((r × r) × 100).
Pearson’s correlation.
As PLT-F (the Fluorescent Platelet Count on the Sysmex XN analyser).
FGFb, basic fibroblast growth factor; IGF-1, insulin-like growth factor-1; PDGF-AB, platelet-derived growth factor AB; TGF-β, transforming growth factor-beta; VEGF, vascular endothelial growth factor.